SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-22-028460
Filing Date
2022-11-04
Accepted
2022-11-04 16:15:23
Documents
2
Period of Report
2022-11-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_166759290728042.html 3  
1 FORM 3 wf-form3_166759290728042.xml 3 1706
2 POA BALDRY MARK powerofattorneybaldry.htm EX-24 3738
  Complete submission text file 0001628280-22-028460.txt   6944
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AMICUS THERAPEUTICS 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Baldry Mark (Reporting) CIK: 0001644137 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 221362506